Comparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose-Reference-Cited by-同舟云学术

Comparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose

Published:2009-09 Issue:13 Volume:54 Page:1149-1153
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Cuisset Thomas,Frere Corinne,Quilici Jacques,Poyet Raphael,Gaborit Bénédicte,Bali Laurent,Brissy Olivier,Morange Pierre-Emmanuel,Alessi Marie-Christine,Bonnet Jean-Louis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Variability in individual responsiveness to clopidogrel clinical implications, management, and future perspectives;Angiolillo;J Am Coll Cardiol,2007

2. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction;Matetzky;Circulation,2004

3. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome;Cuisset;J Thromb Haemost,2006

4. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis;Buonamici;J Am Coll Cardiol,2007

5. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine;Richter;J Pharmacol Exp Ther,2004

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?;Expert Opinion on Drug Metabolism & Toxicology;2024-07-15

2. Time interval of esomeprazole and dual antiplatelet therapy in patients with cardiocerebrovascular diseases;Medicine;2024-03-01

3. The Risk of Drug Interactions in Older Primary Care Patients after Hospital Discharge: The Role of Drug Reconciliation;Geriatrics;2023-12-16

4. Survival, Reintervention, and Value of Open and Endovascular Repair for Chronic Mesenteric Ischemia;Annals of Vascular Surgery;2023-11

5. Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions;Journal of Cardiovascular Development and Disease;2023-06-20